A

Athenex (ATNX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Athenex (ATNX)

Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absor... Read more

  • 0.20
  • 0.20
  • 0.19
  • 1.74
  • 0.2%
  • 119M
  • 643.63k
  • 983.85k
  • 31M
  • 0.16
  • -88.2%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.